Agree Realty Corporation
ADC
Updated: 24/09/2026, 06:09:41
Agree Realty Corporation functions as a publicly traded Real Estate Investment Trust (REIT), concentrating its efforts on the acquisition and development of commercial properties. These assets are primarily net-leased to leading companies within the retail sector. As of September 30, 2020, the firm oversaw a substantial portfolio of 1,027 properties, which were distributed across 45 U.S. states and encompassed a total gross leasable area of approximately 21.0 million square feet. Shares of Agree Realty's common stock are available for trade on the New York Stock Exchange, identified by the ticker symbol ADC.
No summaries found.
- Share price
- $67.12
- Market cap
- $8.06B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Joel N. Agree
- Employees
- 90
- IPO date
- 15/04/1994
- Beta
- 0.457
- Last dividend
- $0.00
- Day range
- $66.50 – $67.54
- 52-week range
- $66.50 – $82.08
- 1-day performance
- -0.30%
- 1-year performance
- 0.93%
- Current drawdown (1Y)
- -18.23%
- CIK
- 0000917251
- CUSIP
- 008492100
- ISIN
- US0084921008
- Created
- 07/12/2025, 01:55:21
- Last update
- 24/09/2026, 06:09:41
Track Agree Realty Corporation with an AI analyst
See which prediction-market events move ADC, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Akeso's Next-Generation HER3 ADC AK138D1 Combined with Ivonescimab: First Patient Enrolled in Phase Ib/II Breast Cancer Study, Advancing the IO2.0 + ADC2.0 Strategy
PRNewsWire • STOCK • 15/06/2026, 04:52:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
GlobeNewsWire • STOCK • 09/06/2026, 15:20:00
A Barbell Approach To Passive Income As Inflation Roars Back To Life
Seeking Alpha • STOCK • 06/06/2026, 10:15:00
REITs May Crash Again- Here's Why, And Two REITs Income Investors Should Consider Buying
Seeking Alpha • STOCK • 05/06/2026, 09:45:00
ADC Therapeutics: ZYNLONTA's Positive Lymphoma Trial Results
Market Data • Market Data • 04/06/2026, 20:01:16
Akari Therapeutics Releases CEO Corner Reflecting on Evolving ADC Landscape and Akari's Differentiated PH1 Payload Platform Following ASCO 2026
GlobeNewsWire • STOCK • 04/06/2026, 11:30:00
ADC Therapeutics plunges after patient deaths in blood cancer drug trial
Reuters • STOCK • 04/06/2026, 10:02:59
U.S. REIT At-The-Market Activity Dips In Q1 2026
Seeking Alpha • STOCK • 28/05/2026, 05:55:00
Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload
PRNewsWire • STOCK • 21/05/2026, 19:05:00
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study
Zacks Investment Research • STOCK • 19/05/2026, 14:50:41
Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities
Newsfile Corp • STOCK • 19/05/2026, 05:15:00
Whitehawk Therapeutics: 'Hold' On Name Change And Next Generation PTK7 ADC Targeting
Seeking Alpha • STOCK • 15/05/2026, 06:25:46